Filana Therapeutics FLNA
NASDAQ FLNA
$0.66 -0.03 (-4.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Filana Therapeutics (FLNA) posted Depreciation & Amortization (CF) of $300,000 for Q2 2026, up 50.0% from $200,000 a year earlier and up 23.5% from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Filana Therapeutics was $1.05 million, up 55.7% year-over-year; for FY2025, it came in at $903,000, down 5.1% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 110.2% (FY2020 to FY2025).
  • In prior years, Filana Therapeutics' Depreciation & Amortization (CF) was $952,000 in FY2024 (-12.2%), $1.08 million in FY2023 (+34.8%), $804,000 in FY2022 (+159.4%) and $310,000 in FY2021.
  • Quarterly Depreciation & Amortization (CF) has run from a low of $52,000 in Q4 2024 to a high of $311,000 in Q1 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last three quarters, with growth averaging 46.7% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2025, with growth of 482.7%; the weakest was Q4 2024, with a decline of 80.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $243,000 (Q1 2026), $303,000 (Q4 2025) and $200,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.96 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 194.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.93 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 98.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.62 Bn
10 Filana Therapeutics 32.11 Mn -338.73 Mn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 243,000.00
Dec 31, 2025 303,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 220,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 311,000.00
Dec 31, 2023 267,000.00
Sep 30, 2023 273,000.00
Jun 30, 2023 272,000.00
Mar 31, 2023 272,000.00
Dec 31, 2022 271,000.00
Sep 30, 2022 181,000.00
Jun 30, 2022 174,000.00
Mar 31, 2022 178,000.00
Dec 31, 2021 179,000.00
Sep 30, 2021 121,000.00
API Access

Filana Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=FLNA&period=max&api_key=YOUR_API_KEY